Cordocentesis is a prenatal test that draws a small sample of blood directly from the baby’s umbilical cord while still in the womb. Also called percutaneous umbilical cord blood sampling (PUBS), it gives doctors a way to diagnose serious fetal conditions, particularly when other prenatal tests can’t provide answers quickly enough or in enough detail. The procedure is typically performed during the second or third trimester and carries a procedure-related pregnancy loss risk of roughly 0.6% above the background rate.
Why Cordocentesis Is Performed
Fetal blood gives doctors information they can’t always get from amniotic fluid or placental tissue. The most common reason for cordocentesis is suspected fetal anemia, which can develop when the mother’s immune system attacks the baby’s red blood cells due to blood type incompatibility. By measuring the baby’s blood counts directly, doctors can determine how severe the anemia is and whether a blood transfusion through the same umbilical cord access is needed.
Other reasons include diagnosing fetal infections (such as toxoplasmosis or cytomegalovirus), checking for genetic chromosome abnormalities, and evaluating blood clotting disorders. In some cases, cordocentesis is chosen over amniocentesis specifically because results come back faster. When a woman is referred late in pregnancy and chromosome results are needed quickly, fetal blood cells can be analyzed more rapidly than the cells floating in amniotic fluid, which need time to grow in a lab before they can be studied.
That said, cordocentesis is not a routine screening test. It’s reserved for situations where less invasive options have already been tried or wouldn’t provide the specific information needed.
How the Procedure Works
Cordocentesis is performed in a hospital or specialized clinic and typically takes only a few minutes. You’ll lie on your back while a technician applies gel to your abdomen and uses ultrasound to locate the baby, the umbilical cord, and the placenta. This real-time imaging guides the entire procedure.
Your doctor may numb a small area of skin on your abdomen with a local anesthetic. A thin needle is then inserted through your abdominal wall, through the uterus, and into a blood vessel in the umbilical cord, usually the vein near where the cord attaches to the placenta. This insertion point is preferred because the cord is most stable there. You may feel stinging, pressure, or mild cramping as the needle goes in. A small volume of fetal blood is drawn, and the needle is removed.
The approach varies depending on where your placenta is positioned. If the placenta sits along the front wall of the uterus, the needle can pass through it directly to reach the cord attachment, which is the easiest and most reliable method. When the placenta is along the back wall, the doctor may need to target a free-floating loop of the cord suspended in amniotic fluid. This is trickier because the cord moves as the needle touches it, requiring a quick, precise puncture.
What the Risks Look Like
A large study of over 6,600 cordocentesis procedures found that the procedure adds about 0.6% to the background risk of pregnancy loss. That means the vast majority of pregnancies continue normally afterward. Earlier estimates placed the risk higher, but improvements in ultrasound technology and operator experience have brought it down considerably. In experienced centers, the current rate of procedure-related loss is under 1%.
The most common immediate complication is temporary bleeding from the puncture site on the umbilical cord, occurring in roughly 20% of cases. This bleeding is usually brief and stops on its own. A temporary drop in the baby’s heart rate (bradycardia) happens in about 5% of procedures, and it also typically resolves without intervention. Small amounts of the baby’s blood can leak into the mother’s circulation in up to 40% of cases, which is more likely when the placenta is on the front wall, when the procedure takes longer than three minutes, or when the needle needs to be inserted more than once.
Infection is rare, occurring in about 1% of procedures. In roughly 5 to 10% of attempts, the doctor is unable to successfully obtain a fetal blood sample, which may require rescheduling the procedure.
How It Compares to Amniocentesis
Amniocentesis samples the fluid surrounding the baby rather than the baby’s blood. For many genetic tests, amniocentesis works well and carries a somewhat lower risk profile. But it has a significant limitation: the fetal cells collected from amniotic fluid need to be cultured in a lab for days or even weeks before chromosome analysis can be completed.
Cordocentesis bypasses that waiting period. Fetal blood cells can be analyzed directly, producing chromosome results faster. This speed advantage matters most when a diagnosis is needed urgently later in pregnancy, for example if an ultrasound at 28 weeks reveals an unexpected abnormality. Cordocentesis also provides information that amniocentesis simply cannot, like a complete blood count, blood gas levels, and direct evidence of active infection in the baby’s bloodstream.
What to Expect During Recovery
The procedure itself is brief, and you’ll likely be monitored for a period afterward while your medical team checks the baby’s heart rate with ultrasound. Some cramping or soreness at the needle site is normal. Most women are advised to take it easy for the rest of the day and avoid strenuous physical activity for a short period, though specific instructions vary by provider.
Results depend on what’s being tested. A basic blood count to check for anemia can be available within hours. Chromosome analysis from fetal blood is significantly faster than from amniocentesis, often returning within 48 to 72 hours, though some specialized tests may take longer. Your doctor will typically discuss findings with you as soon as they’re available, especially if the results point toward a condition that requires immediate treatment like a fetal blood transfusion.
Who Performs Cordocentesis
This is a highly specialized procedure performed by maternal-fetal medicine specialists with specific training in ultrasound-guided fetal interventions. Operator experience is one of the most important factors in safety outcomes. The large study that reported the 0.6% incremental loss rate noted that early in a center’s experience, before operators had completed extensive training, complication rates were higher. Outcomes improved significantly once procedural volume increased, reinforcing that this is not a test performed at every obstetric practice. If cordocentesis is recommended, you’ll typically be referred to a specialized fetal medicine center.

